Not even manipulation, flat out relentless selling of shares that they never plan on buying back. They have shorted so many shares that they have a real good idea that BFAR has nothing legitimate about it. I just wonder how much longer/how many more shares they will be able to get off before the SEC puts a halt to it. It is a daily printing press. I would love to know what the float looks like today versus 6 months ago. They are just creating new shares everytime the place a sale.

Shorts were able to get off another 185,000 shares on Friday. 90% of the volume. Must be nice to print money like that.

Thanks, They sure aren't pounding away like the past.

Anyone see VFIN on the ask anymore?

Berkower wouldn't disclose their engagement as of 1/29/2012 so we need to see what they say next update. I wonder what their source is and how frequently they update.

That is the best news I have seen in a long time if it is current. Not sure how frequently they update, but nice to see they engaged and dismissed Universal Travel Group. No dismissal yet.

Sun, didn't see your post. Can you do a brief rehash so I can get a sense as to what information you put out there? I think the moderators should go easy on deleting posts and let others complain/voice concerns etc on inappropriate posts.

You have to assume the audit process is concluded and the firm is no longer engaged. There has been no confirmation that the stated financials are legit hence no filings. ACSB will no longer confirm that they are engaged. I have to assume that there is no company currently auditing the books. We are waiting for something that isn't even coming!! Can we a least acknowledge this as being a likely scenario. When ACSB jumped ship, it wasn't their responsibility to tell us.

Not sure why March 31st has any relevance on current financials being filed??????????????? Past financials need to be filed first. For the love of God, pay attention.

I have to assume they never sold the company to the guys that wanted to go private. The price they disclosed was far to cheap and was the first inkling that I had that something was not right with these guys. Never an 8-K finalizing the transaction or the purchase of the other distribution arm which was later liquidated.

I can save you guys the time on Kenneth Wong and Elite Capital Group. Dead end everywhere. For a managing director to not be found associated with a company is unheard of. Kenneth Wong through PWC isn't verifiable.

I know that Hubei HolleyZhengyuan Pharmaceutical Company Limited ("HBHLZY" deal didn't go through. I saw a while back that they were being liquidated.

I don't doubt the sales numbers, I have a hard time confirming who is the direct owner of them. That is where the hang up is with this mess. Does Biopharm Asia actually own all of these subsidiaries?

check the bottom of the article. Below about Biopharm asia.

Source: Marketwatch

About BioPharm Asia, Inc.

BioPharm Asia, Inc. is engaged in the retail sale of medical products in China, complemented by vertically integrated supporting functions that include the cultivation of Chinese herbal medicines, pharmaceutical production and wholesale medicine distribution.

SOURCE: marketwatch.com

Editorial Message
This site contains materials from other clearly stated media sources for the purpose of discussion stimulation and content enrichment among our members only.
whatsonxiamen.com does not necessarily endorse their views or the accuracy of their content. For copyright infringement issues please contact editor@whatsonxiamen.co

This press release hasn't been verified. The xiamen website picked up the story from Marketwatch due to the BFAR ticker symbol. You need to find something from the hospital as the source not a duplicate of the same pr. Not trying to belittle your findings, just stating the facts as I have been on this for quite sometime.

Gamble it is. So many loose ends on this thing. I have spent hours verifying every pr and haven't been able to confirm one.

0.07 is the new 0.06. Unlimited shares for sale. VFIN selling whatever someone is willing to buy.

Lucky, yes you are correct in your statement and whoever the buyer is, is the one paying for the trade as the MM receives payment upon settlement.

Dear Mr xxxx,

Thank you for your enquiry. Please kindly note that this Kenneth Wong of
PwC is not the one you are looking for.

Kind regards,
Web Services Team





An enquiry has been sent on 31 Dec 2011 12:23 am to Kenneth Wong.

Thank you from the PwC Web Services Team (based in Hong Kong).
--------------------------------------------------------------------------
--------------------------------------------------------------------------
--------------------------

Reference No:
HK-2011-12-019154

Link to the referring web page:
http://www.pwchk.com/home/eng/kennethwong.html

Subject:
BioPharm Asia

Message:
Hi Kenneth, I am doing some due diligence on a company called BioPharm
asia that recently appointed a Kenneth Wong as a independent director of
their company. I was looking for confirmation if you are the same Kenneth
Wong that is mentioned in the press release. The press release eludes to
the fact that their Kenneth Wong does not work at PWC any longer so I am
trying to get clarity on that. Thanks for your time. NEW YORK, NY and
TONGHUA, CHINA -- (MARKETWIRE) -- 12/08/11 -- BioPharm Asia, Inc.
(BFAR:$0.0463,$-0.0062,-11.81%) , a producer, distributor and retailer of
medical products in China, today announced appointment of independent
director. On December 8, 2011, the Company's board of directors appointed
Mr. Kenneth Wong, age 47, as independent director of the Company,
effective immediately. Mr. Xiayang Hu, Chief Executive Officer of BioPharm
Asia (BFAR:$0.0463,$-0.0062,-11.81%) , said, "We are pleased to welcome
Ken to our board. With nearly 20 years of healthcare and financial
experience in serving senior management positions including President and
Chief Operating Officer, we believe Ken will make wise contributions to
the board's deliberations and decisions -- in leadership, strategy,
management, and in operations practice. Plus his prior corporate
compliance expertise, will serve our board well to meet our regulatory
filing requirements." Formerly, Mr. Wong held senior-level financial
positions at Pacific Bridge Medical (1991 - 2002), were he was responsible
for, and oversaw Healthcare Staffing, Specialty Pharmaceutical
Distribution/Infusion Therapy and Network Management lines of business.
Mr. Wong supervised the pharmaceuticals practice at Pricewaterhouse
Coopers Hong Kong (2002 - 2010). Serving as a tax partner at PwC, Mr. Wong
had a broad range of domestic and international medical technology,
pharmaceutical and biotechnology clients. He was integral in the company's
IT, risk management, mergers and acquisitions activities. Mr. Wong is a
graduate of the University of Kentucky and is professionally affiliated
with the American Institute of Certified Public Accountants, Hong Kong
Society of Certified Public Accountants, and the Healthcare Financial
Management Association.

Not the same Kenneth Wong. Been down this road. Received e-mail from PWC stating this is not the Kenneth Wong we are looking for. This guy is still with PWC,

Loupai, IMO the VFIN issue is just so in the forefront because they are constantly on the ask and the number of shares shorted are close to 60% of the volume each trading day. They are responsible for the downward pressure whether they are directly shorting for the firm, shorting for a client, or simply just selling a clients position. I doubt it is the last one just due to the amount of shares being shorted.

Now think about this scenario as to what could be going on here: Keep in mind this is just a crazy idea that I came up with and nothing of factual substance.

The question begs as to why the sudden spike in volume and price appreciation? We know there is no news and anyone speculating that this trade is front-running any audited numbers is outlandish at best.

So I assume that VFIN is shorting as many shares of BFAR they can. They have unloaded millions at 0.06 in hope of never buying the shares back, therefore reaping 100% gain on every trade minus the margin interest. Not sure how/if you close a position that goes to zero but that is besides the point. Now, take Firm number 2, deeper pockets than VFIN and is aware of the size of a short position they put on over the last few months. They begin to try to put a bullish trade on BFAR, not anything to do with the company, financials, hospitals, directors, etc but a pure bully trade on the upside. They begin buying and blow through the 0.06 that VFIN has been standing on, VFIN pulls away from the trade and allows firm 2 to continue buying shares, driving the price up only to try to short more at a higher price. The issue being that firm # 2 has deep pockets and can continue to buy shares and knock off every ask therefore driving margin calls for VFIN. If they can continue buying and cause enough pain, say BFAR can get to 0.18, 200% gain on some shares to VFIN running a 200% loss, VFIN will need to cover and begin to buy the shares back. As they begin to cover, firm # 2 supplies the shares to VFIN and therefore can begin to exit their position while having the price rise due to VFIN being forced to buy back shares. While this is going on, retail traders are jumping on the bull trade just making matters worse for VFIN.
I see it as a predatory move to the opposite of what shorts usually do to shitty companies and I can see firm #2 doing it out of spite or just that they have the financial ability to pull it off and still don't give a shit about BFAR as a company or its shareholders but just see it as a money making trade and can put the hurt on a competitor or just smaller fish.

This could be complete crazy thinking but in my mind it makes more sense than believing BFAR has the goods and legit numbers are being posted to the SEC tommorow.

Thanks for the post Tim. Not good news to say the least. Makes you wonder if any of this has any legitimacy.

"weekend pocket change by shorting, naking short, full clothed shorting, big and tall suit short,"

LOL, now that was funny!!!!!

Loupai, how frequently did you contact Maurice? I ran into the same response last week and am wondering if he is tired of us constantly inquiring about the audit and that is why he dumps us off to the company or do you think that they are no longer engaged and therefore he doesn't feel the responsibility to bring that fact to the public?

Don't let the 0.05 fool you into thinking it can't be a profiatble trade. Approx 17 million shares have traded since the unaudited financials have come out. The short trade here is to take the stock to zero and never cover which has to be the mindset to take that risk here. That is 100% profit on every share they sell so hypothetically if they were behind half of all shares sold you are looking at over $400,000 gain if BFAR is fraud. Seems like a great bet right about now with the long list of frustrations you and I both have on trying to substantiate anything about the company.

Loupai, good to have you back.
I agree on all your points except for the VFIN part. They are the ones putting constant downward pressure with the never ending supply at 0.06. Whether they as a firm are doing it or they are trading for a client they relentlessly sell at this level. Then you look at the short interest for the day and all of those shares are coming from them. That begs the question as to why? That is the relevance in my eyes. Sure, audited financials come out and it all means nothing, but until then, it seems that they have the knowledge to bet against the company and have been winnning so far.

The 5000 shares at 0.06 isn't very transparent as 49,500 just went through and it didn't budge.

didn't call, mainly due to the language barrier and I'm hesitant that the number is fake and I will get some whacked out international phone bill if I try. LOL

Rdoggy, the real question which I can't get a handle on is out of all of these acquisitions/buyouts/mergers etc, there is no real proof of ownership by Biopharm Asia. From my DD, the pharmaceutical company has product and lots of it, the hospital management company is real, and the drug stores are legitimate operations. The problem is and I think is why this is such a speculative investment and priced accordingly is that there is no way to tie all of these entities back to Biopharm Asia. The shorts seem content that there will be no way to bring this full circle and show credibility, hence why they are willing to short at 0.06.
On a seperate note, is there any proof to show that ACSB is still working on the financials we are all waiting for? It will be one full year this month and we still have nothing to show for it. I can't get confirmation whether they are on board or not but would hate to find out that ACSB parted ways and we are waiting on audited results that aren't even being worked on. If ACSB is still engaged, what are they doing/ have been doing the last year?

Also, why is there no e-mail for Gloria Fang or any way to contact the company? They have put out the unaudited financials, the appointment of the new boardmember, the purchase of a hospital, and there is no way to verify any of it. I can't find their Kenneth Wong anywhere. The Kenneth Wong at PWC isn't the same guy. Tongji Hospital, 300 beds?? I can't find anyone in Xiamen that actually knows that the place exists. But then I have to say to myself, who could sit there and make this shit up? Some great fictional author could be on the hook since the press releases seem so believable on the surface.

So now I look at a company with a market cap of $3 million. Any idea what a hospital costs? 300 beds??? Equipment, staff etc. I can guess a hell of a lot more than what BFAR is worth today.
Either the entire thing is a fictitous dream that is being played out scene by scene or there is a serious valuation miss by the street.

The aggressive short position being taken is alarming at this price. Almost makes one believe VFIN knows that financials are never coming out and they will relentlessly sell shares above 0.05 to any willing buyer with no plan to ever have to cover the position.

Nice, thanks for the link.

Rdoggy, how can you tell that they are naked shorts? Do you have a way of knowing how many are actually out there on the short interest? Thanks

Luck, I hope you are correct on the dilution statement. I still wonder where all these shares come from on VFIN. I pray that these press releases aren't designed as a stunt to give liquidity to a bunch of unauthorized shares.

who is on ask at 0.0688?

http://www.china.org.cn/english/travel/42434.htm

BioPharm Asia Acquires Specialty Hospital in Fujian 01/26 09:00 AM



NEW YORK, NY and TONGHUA, CHINA -- (MARKETWIRE) -- 01/26/12 -- BioPharm Asia, Inc. (BFAR:$0.054,0$0.00,000.00%) (the "Company") announced today that the company entered into an agreement to acquire Xiamen Tongji Hospital, a privately owned gynecology, obstetrics center based in Fujian province, China, for an undisclosed amount. Upon completion of the acquisition, BioPharm Asia (BFAR:$0.054,0$0.00,000.00%) will be responsible for the daily operation of the medical center. The deal is contingent upon approval from the Ministry of Commerce and is expected to close in the first quarter of 2012.
Tongji Hospital is a 300 patient bed hospital. Founded in 1993, with a well-echeloned staff structure, it offers a full range of gynecology services at a convenient geographic location. The acquisition of Xiamen Tongji Hospital accelerates BioPharm Asia's (BFAR:$0.054,0$0.00,000.00%) strategy, which aims to increase the accessibility of patient care for big cities with underserved, growing affluent middle class in China.
"BioPharm Asia (BFAR:$0.054,0$0.00,000.00%) continues to invest in the key emerging markets such as Xiamen where the combination of growing populations and increasing income are driving demand and expectations for better healthcare treatment," said Xiayang Hu, president of BioPharm Asia, Inc. (BFAR:$0.054,0$0.00,000.00%) "Our new acquisition further underscores our intention to serve the health needs of Xiamen patients through our specialized services and, increasingly, high-quality branded generic treatments that are locally produced to global standards."
"As China's economy has continuously made stride in recent history, a rising middle class with greater spending power demands higher quality of healthcare, but the truth is that they don't have many alternatives to choose. The company's new marketing plans should be able to make inroads with increasingly health-conscious urban customers."

This reinforces the press release that they were hired for that new hospital to the point that they must have employees to have salaries.

Reference of products through the state!

http://translate.google.com/translate?hl=en&sl=zh-CN&u=http://gsp.qw168.com/show.php%3Fitemid%3D385864&ei=Z1McT_3XB8qTtwe62qi0Cw&sa=X&oi=translate&ct=result&resnum=6&ved=0CFwQ7gEwBTgU&prev=/search%3Fq%3D%25E9%2580%259A%25E5%258C%2596%25E7%259B%259B%25E5%25AE%2589%25E5%25A0%2582%25E5%258C%25BB%25E8%258D%25AF%25E8%25BF%259E%25E9%2594%2581%25E6%259C%2589%25E9%2599%2590%25E5%2585%25AC%25E5%258F%25B8%26start%3D20%26hl%3Den%26client%3Dfirefox-a%26sa%3DN%26rls%3Dorg.mozilla:en-US:official%26noj%3D1%26biw%3D1170%26bih%3D541%26prmd%3Dimvns

Wages would lead you o believe that they actually have employees across China.

http://translate.google.com/translate?hl=en&sl=zh-CN&u=http://www.jobui.com/salary%3FjobKw1%3D%25E9%2580%259A%25E5%258C%2596%25E7%259B%259B%25E5%25AE%2589%25E5%25A0%2582%25E5%258C%25BB%25E8%258D%25AF%25E8%25BF%259E%25E9%2594%2581%25E6%259C%2589%25E9%2599%2590%25E5%2585%25AC%25E5%258F%25B8%26cityKw1%3D&ei=5k8cT8OlEsa2twfx8YH2DA&sa=X&oi=translate&ct=result&resnum=4&ved=0CE0Q7gEwAzgU&prev=/search%3Fq%3D%25E9%2580%259A%25E5%258C%2596%25E7%259B%259B%25E5%25AE%2589%25E5%25A0%2582%25E5%258C%25BB%25E8%258D%25AF%25E8%25BF%259E%25E9%2594%2581%25E6%259C%2589%25E9%2599%2590%25E5%2585%25AC%25E5%258F%25B8%26start%3D20%26hl%3Den%26client%3Dfirefox-a%26sa%3DN%26rls%3Dorg.mozilla:en-US:official%26noj%3D1%26biw%3D1170%26bih%3D541%26prmd%3Dimvns

Impressive list of products.

http://translate.google.com/translate?hl=en&rurl=translate.google.com&sl=zh-CN&tl=en&u=http://www.3156.cn/company/200712/346304.shtml

One would think these guys have a balance sheet/income statement the size of General Electric's with how long this audit is taking. Over one year to audit the books of a company with a market cap of 2.5 million???? I just find myself shaking my head as to what is going on with this whole process.